In the quiet cellular landscape of the mouth, a molecular signal called IL-1α has been found to act as a kind of saboteur — turning the body's own immune cells into unwitting accomplices of precancerous growth. Researchers at MD Anderson Cancer Center have traced the pathway by which some oral lesions evade detection and become invasive cancer, while others never do. The discovery offers not only a potential explanation for a long-standing clinical uncertainty, but also a possible means of intervention — a chance to act before the body's defenses have been fully disarmed.